David Jungck
Berlin, BE 12207, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD.
Journal: International journal of molecular sciences
Published: April 26, 2021
LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD.
Journal: Journal of clinical medicine
Published: October 09, 2019
The monocyte-dependent immune response to bacteria is suppressed in smoking-induced COPD.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: June 05, 2018
The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.
Journal: Current molecular medicine
Published: December 18, 2016
Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease.
Journal: The Journal of allergy and clinical immunology
Published: September 08, 2016
TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.
Journal: Biochemical pharmacology
Published: May 10, 2016
Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
Journal: European journal of pharmacology
Published: November 19, 2015
Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
Journal: European journal of pharmacology
Published: June 05, 2015
A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: December 03, 2014
Endothelin receptor B protects granulocyte macrophage colony-stimulating factor mRNA from degradation.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 22, 2014
Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
Journal: The Journal of pharmacology and experimental therapeutics
Published: May 31, 2013
Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
Journal: Basic & clinical pharmacology & toxicology
Published: May 26, 2013
Last Updated: 09/26/2026